Gray platelet syndrome is a rare inherited bleeding disorder characterized by platelets that have a gray appearance. Platelets are normally colorless and clot blood in the body, this can cause severe thrombocytopenia, myelofibrosis, and splenomegaly. About 60 cases from various populations around the world have been reported worldwide. Gray platelet syndrome results from the absence or reduction of alpha-granules in platelets, which store proteins that promote platelet adhesiveness and wound healing when secreted during an injury. Gray platelet syndrome is caused by mutations in the gene NBEAL2.
Gray Platelet Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Gray Platelet Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 1013 products for the study of Gray Platelet Syndrome that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Gray Platelet Syndrome is also known as gray platelet syndrome, platelet alpha-granule deficiency, marked decrease or absence of alpha-granules and of platelet-specific alpha-granule proteins, platelet-type bleeding disorder 4, bdplt4, gps.